AI assistant
Nayax Ltd. — Director's Dealing 2026
May 19, 2026
6940_rns_2026-05-19_78f8d8f1-bd0d-476d-a8e8-31ac6b1772b8.pdf
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
| 1. Name and Address of Reporting Person* Sever Michal | 2. Issuer Name and Ticker or Trading Symbol Nayax Ltd. [NYAX] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (Last) (First) (Middle) 3 ARIK EINSTEIN BUILDING B FLOOR 1 | 2a. Foreign Trading Symbol | ||||||||||
| 3. Date of Earliest Transaction (Month/Day/Year) 05/15/2026 | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | ||||||||||
| (Street) HERZLIYA | 4. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||
| (City) (State) (Zip) | |||||||||||
| ISRAEL (Country) | |||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |||||||||||
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | Amount | (A) or (D) | Price | |||||||
| Ordinary Shares | 05/15/2026 | M | 1,563(1) | A | $21.352(2) | 18,869 | D | ||||
| Ordinary Shares | 05/15/2026 | S | 1,563(3) | D | $64.4123(4) | 17,306 | D | ||||
| Ordinary Shares | 05/15/2026 | M | 3,437(1) | A | $21.352(2) | 20,743 | D | ||||
| Ordinary Shares | 05/15/2026 | S | 3,437(3) | D | $64.2803(4) | 17,306 | D | ||||
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | ||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | ||||||
| Stock Option (Right to Buy) | $21.352(2) | 05/15/2026 | M(5) | 1,563 | 03/30/2025 | 03/28/2027 | Ordinary Shares | 1,563 | |||
| Stock Option (Right to Buy) | $21.352(2) | 05/15/2026 | M(5) | 3,437 | 03/28/2023 | 03/28/2027 | Ordinary Shares | 3,437 |
Explanation of Responses:
- The shares were acquired upon the exercise of stock options
- The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
- The shares sold were acquired upon the exercise of stock options on the same date
-
The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request. The sale price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the Execution date.
-
The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
Michal Sever by:
Oppenheimer Israel, as
Attorney-in-fact
Signature of Reporting Person
05/18/2026
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
- Form 4: SEC 1474 (03-26)